CASP3 and neoplasm: As with the previous in vitro studies, we observed increases in caspase-3 and PARP cleavage concomitant with MYCN loss in both Kelly NB tumor xenografts and TH-MYCN tumors following treatment with CYC065 (Figure 6, F–H).